Lenvatinib combined with sintilimab plus transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma

doi:10.12998/wjcc.v12.i2.285

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1304)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

WORD

HTML

690

Tables (1-3)

124

Sum=964

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

112

Download

178

Sum=290

Jan 16, 2024 (publication date) through Jul 18, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Jan 16, 2024; 12(2): 285-292
Published online Jan 16, 2024. doi: 10.12998/wjcc.v12.i2.285

Table 2 Tumor best response, n (%)

Response	Patients (n = 40)
CR	5 (12.5)
PR	13 (32.5)
SD	18 (45)
PD	4 (10)
ORR	18 (45)
DCR	36 (90)

CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progressive disease; ORR: Objective response rate; DCR: Disease control rate.

Citation: Sun SS, Guo XD, Li WD, Chen JL. Lenvatinib combined with sintilimab plus transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma. World J Clin Cases 2024; 12(2): 285-292
URL: https://www.wjgnet.com/2307-8960/full/v12/i2/285.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i2.285